Las Vegas, NV -- (SBWIRE) -- 10/10/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: equenom, Inc. (NASDAQ:SQNM), ParkerVision, Inc. (NASDAQ:PRKR), Odyssey Marine Exploration Inc (NASDAQ:OMEX), Opexa Therapeutics Inc (NASDAQ:OPXA)
Sequenom, Inc. (NASDAQ:SQNM) managed to keep its fall at 0.40% on below -normal volume of 1.69M shares. The stock settled at $2.51 after floating in a range of $2.45 to $2.57. Its latest price has reached market capitalization of $289.56 million. Its 52-week range has been $2.45 to $5.36. Sequenom, Inc. (Sequenom) is a molecular diagnostic testing and genetics analysis company committed to providing molecular diagnostic testing services, and research use only products, services, applications, and genetic analysis products that translate the results of genomic science into solutions for biomedical research.
For How Long SQNM will fight for Profitability? Read This Trend Analysis report
ParkerVision, Inc. (NASDAQ:PRKR) traded down on a volume of 1.64 million, higher than its standard daily volume. Shares have dropped-10.49% to $2.73. Over the last twelve months, the stock has gained 16.67% and faced a worst price of $252.28. ParkerVision, Inc. (ParkerVision), is engaged in the business of designing, developing and selling its radio frequency (RF) technologies and products for use in semiconductor circuits for wireless communication products.
Has PRKR Found The Bottom And Ready To Gain Momentum? Find Out Here
Odyssey Marine Exploration Inc (NASDAQ:OMEX) settled -5.05% lower at $2.63 on above-normal volume of 1.60M shares during the last trading day. The stock has its 12-month high at $3.70 and 52-week low price was $2.41. It traded in a range of $2.61 to $2.81 during the last trading day. Odyssey Marine Exploration, Inc. is engaged in archaeologically sensitive exploration and recovery of deep-ocean shipwrecks worldwide.
Will OMEX Get Buyers Even After The Recent Rally? Find Out Here
In the last trading session, Opexa Therapeutics Inc (NASDAQ:OPXA) was down on high volume, trading at a volume of 1.55M versus its average daily volume of 1.15 million shares. At $1.79, the stock has attained market capitalization of 40.69 million. Opexa Therapeutics, Inc. (Opexa) is a biopharmaceutical company. The Company is engaged in developing personalized cellular therapies with the potential to treat illnesses, including multiple sclerosis (MS). These therapies are based on its T-cell technology.
Why Should Investors Buy OPXA After the Recent Fall? Just Go Here and Find Out
About Equity Observer
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)